References
1. Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric
Cancer. Lancet (2020) 396(10251):635-648. Epub 2020/08/31. doi:
10.1016/S0140-6736(20)31288-5.
2. Werner S, Chen H, Butt J, Michel A, Knebel P, Holleczek B, et al.
Evaluation of the Diagnostic Value of 64 Simultaneously Measured
Autoantibodies for Early Detection of Gastric Cancer. Sci Rep(2016) 6:25467. Epub 2016/05/04. doi: 10.1038/srep25467.
3. Kayamba V, Zyambo K, Kelly P. Presence of Blood in Gastric Juice: A
Sensitive Marker for Gastric Cancer Screening in a Poor Resource
Setting. PLoS One (2018) 13(10):e0205185. Epub 2018/10/16. doi:
10.1371/journal.pone.0205185.
4. Necula L, Matei L, Dragu D, Neagu AI, Mambet C, Nedeianu S, et al.
Recent Advances in Gastric Cancer Early Diagnosis. World J
Gastroenterol (2019) 25(17):2029-2044. Epub 2019/05/23. doi:
10.3748/wjg.v25.i17.2029.
5. Pentakota S, Zhou K, Smith C, Maffini S, Petrovic A, Morgan GP, et
al. Decoding the Centromeric Nucleosome through Cenp-N. Elife(2017) 6. Epub 2017/12/28. doi: 10.7554/eLife.33442.
6. Schueler MG, Sullivan BA. Structural and Functional Dynamics of Human
Centromeric Chromatin. Annu Rev Genomics Hum Genet (2006)
7:301-313. Epub 2006/06/08. doi: 10.1146/annurev.genom.7.080505.115613.
7. McKinley KL, Cheeseman IM. The Molecular Basis for Centromere
Identity and Function. Nat Rev Mol Cell Biol (2016) 17(1):16-29.
Epub 2015/11/26. doi: 10.1038/nrm.2015.5.
8. Kops GJ, Weaver BA, Cleveland DW. On the Road to Cancer: Aneuploidy
and the Mitotic Checkpoint. Nat Rev Cancer (2005) 5(10):773-785.
Epub 2005/10/01. doi: 10.1038/nrc1714.
9. Johnson SC, McClelland SE. Watching Cancer Cells Evolve through
Chromosomal Instability. Nature (2019) 570(7760):166-167. Epub
2019/06/12. doi: 10.1038/d41586-019-01709-2.
10. Tanaka K, Hirota T. Chromosomal Instability: A Common Feature and a
Therapeutic Target of Cancer. Biochim Biophys Acta (2016)
1866(1):64-75. Epub 2016/06/28. doi: 10.1016/j.bbcan.2016.06.002.
11. McAinsh AD, Meraldi P. The Ccan Complex: Linking Centromere
Specification to Control of Kinetochore-Microtubule Dynamics.Semin Cell Dev Biol (2011) 22(9):946-952. Epub 2011/10/27. doi:
10.1016/j.semcdb.2011.09.016.
12. Yan K, Yang J, Zhang Z, McLaughlin SH, Chang L, Fasci D, et al.
Structure of the Inner Kinetochore Ccan Complex Assembled onto a
Centromeric Nucleosome. Nature (2019) 574(7777):278-282. Epub
2019/10/04. doi: 10.1038/s41586-019-1609-1.
13. Friedman S, Freitag M. Evolving Centromeres and Kinetochores.Adv Genet (2017) 98:1-41. Epub 2017/09/26. doi:
10.1016/bs.adgen.2017.07.001.
14. Freitag M. The Kinetochore Interaction Network (Kin) of Ascomycetes.Mycologia (2016) 108(3):485-505. Epub 2016/02/26. doi:
10.3852/15-182.
15. McKinley KL, Sekulic N, Guo LY, Tsinman T, Black BE, Cheeseman IM.
The Cenp-L-N Complex Forms a Critical Node in an Integrated Meshwork of
Interactions at the Centromere-Kinetochore Interface. Mol Cell(2015) 60(6):886-898. Epub 2015/12/25. doi:
10.1016/j.molcel.2015.10.027.
16. Mellone BG, Grive KJ, Shteyn V, Bowers SR, Oderberg I, Karpen GH.
Assembly of Drosophila Centromeric Chromatin Proteins During Mitosis.PLoS Genet (2011) 7(5):e1002068. Epub 2011/05/19. doi:
10.1371/journal.pgen.1002068.
17. Wu H, Zhou Y, Wu H, Xu L, Yan Y, Tong X, et al. Cenpn Acts as a
Novel Biomarker That Correlates with the Malignant Phenotypes of Glioma
Cells. Front Genet (2021) 12:732376. Epub 2021/10/15. doi:
10.3389/fgene.2021.732376.
18. Wang Q, Yu X, Zheng Z, Chen F, Yang N, Zhou Y. Centromere Protein N
May Be a Novel Malignant Prognostic Biomarker for Hepatocellular
Carcinoma. PeerJ (2021) 9:e11342. Epub 2021/05/15. doi:
10.7717/peerj.11342.
19. Zheng Y, You H, Duan J, Chen B, Wu C, Chen P, et al. Centromere
Protein N Promotes Lung Adenocarcinoma Progression by Activating
Pi3k/Akt Signaling Pathway. Genes Genomics (2022)
44(9):1039-1049. Epub 2022/02/13. doi: 10.1007/s13258-021-01215-8.
20. Steven A, Seliger B. The Role of Immune Escape and Immune Cell
Infiltration in Breast Cancer. Breast Care (Basel) (2018)
13(1):16-21. Epub 2018/06/29. doi: 10.1159/000486585.
21. Fridman WH, Galon J, Dieu-Nosjean MC, Cremer I, Fisson S, Damotte D,
et al. Immune Infiltration in Human Cancer: Prognostic Significance and
Disease Control. Curr Top Microbiol Immunol (2011) 344:1-24. Epub
2010/06/01. doi: 10.1007/82_2010_46.
22. Hellwig D, Emmerth S, Ulbricht T, Doring V, Hoischen C, Martin R, et
al. Dynamics of Cenp-N Kinetochore Binding During the Cell Cycle.J Cell Sci (2011) 124(Pt 22):3871-3883. Epub 2011/11/22. doi:
10.1242/jcs.088625.
23. Cheeseman IM, Desai A. Molecular Architecture of the
Kinetochore-Microtubule Interface. Nat Rev Mol Cell Biol (2008)
9(1):33-46. Epub 2007/12/22. doi: 10.1038/nrm2310.
24. Palmer DK, O’Day K, Trong HL, Charbonneau H, Margolis RL.
Purification of the Centromere-Specific Protein Cenp-a and Demonstration
That It Is a Distinctive Histone. Proc Natl Acad Sci U S A (1991)
88(9):3734-3738. Epub 1991/05/01. doi: 10.1073/pnas.88.9.3734.
25. Foltz DR, Jansen LE, Black BE, Bailey AO, Yates JR, 3rd, Cleveland
DW. The Human Cenp-a Centromeric Nucleosome-Associated Complex.Nat Cell Biol (2006) 8(5):458-469. Epub 2006/04/20. doi:
10.1038/ncb1397.
26. Chittori S, Hong J, Saunders H, Feng H, Ghirlando R, Kelly AE, et
al. Structural Mechanisms of Centromeric Nucleosome Recognition by the
Kinetochore Protein Cenp-N. Science (2018) 359(6373):339-343.
Epub 2017/12/23. doi: 10.1126/science.aar2781.
27. Tian T, Li X, Liu Y, Wang C, Liu X, Bi G, et al. Molecular Basis for
Cenp-N Recognition of Cenp-a Nucleosome on the Human Kinetochore.Cell Res (2018) 28(3):374-378. Epub 2018/01/20. doi:
10.1038/cr.2018.13.
28. Carroll CW, Silva MC, Godek KM, Jansen LE, Straight AF. Centromere
Assembly Requires the Direct Recognition of Cenp-a Nucleosomes by
Cenp-N. Nat Cell Biol (2009) 11(7):896-902. Epub 2009/06/23. doi:
10.1038/ncb1899.
29. Carroll CW, Milks KJ, Straight AF. Dual Recognition of Cenp-a
Nucleosomes Is Required for Centromere Assembly. J Cell Biol(2010) 189(7):1143-1155. Epub 2010/06/23. doi: 10.1083/jcb.201001013.
30. Qi CL, Huang ML, Zou Y, Yang R, Jiang Y, Sheng JF, et al. The
Irf2/Cenp-N/Akt Signaling Axis Promotes Proliferation, Cell Cycling and
Apoptosis Resistance in Nasopharyngeal Carcinoma Cells by Increasing
Aerobic Glycolysis. J Exp Clin Cancer Res (2021) 40(1):390. Epub
2021/12/12. doi: 10.1186/s13046-021-02191-3.
31. Oka N, Kasamatsu A, Endo-Sakamoto Y, Eizuka K, Wagai S, Koide-Ishida
N, et al. Centromere Protein N Participates in Cellular Proliferation of
Human Oral Cancer by Cell-Cycle Enhancement. J Cancer (2019)
10(16):3728-3734. Epub 2019/07/25. doi: 10.7150/jca.32281.
32. Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et
al. Understanding the Tumor Immune Microenvironment (Time) for Effective
Therapy. Nat Med (2018) 24(5):541-550. Epub 2018/04/25. doi:
10.1038/s41591-018-0014-x.
33. Sahin Ozkan H, Ugurlu MU, Yumuk PF, Kaya H. Prognostic Role of
Immune Markers in Triple Negative Breast Carcinoma. Pathol Oncol
Res (2020) 26(4):2733-2745. Epub 2020/07/19. doi:
10.1007/s12253-020-00874-4.
34. Vilarino N, Bruna J, Bosch-Barrera J, Valiente M, Nadal E.
Immunotherapy in Nsclc Patients with Brain Metastases. Understanding
Brain Tumor Microenvironment and Dissecting Outcomes from Immune
Checkpoint Blockade in the Clinic. Cancer Treat Rev (2020)
89:102067. Epub 2020/07/19. doi: 10.1016/j.ctrv.2020.102067.
35. Curigliano G. Gyneco-Oncological Genomics and Emerging Biomarkers
for Cancer Treatment with Immune-Checkpoint Inhibitors. Semin
Cancer Biol (2018) 52(Pt 2):253-258. Epub 2018/05/19. doi:
10.1016/j.semcancer.2018.05.004.
36. Sun R, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, et
al. A Radiomics Approach to Assess Tumour-Infiltrating Cd8 Cells and
Response to Anti-Pd-1 or Anti-Pd-L1 Immunotherapy: An Imaging Biomarker,
Retrospective Multicohort Study. Lancet Oncol (2018)
19(9):1180-1191. Epub 2018/08/19. doi: 10.1016/S1470-2045(18)30413-3.